| Uniprot ID: | |
| Secondary ID: | |
| Symbol: | miR-155 |
| Other Name: | |
| Class: | Epigenetics |
| Type: | pro/anti-fibrotic |
| Molecular Function: |
| Category I | Category II | Category III |
|---|---|---|
| Intracellular | Epigenetics | microRNA |
Reference Record 1
| PubMed ID | 28607031 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | EndoMT | ||
| Process III | |||
| Mechanism | Targeting TGF-β/miR-155/c-Ski signaling | ||
Reference Record 2
| PubMed ID | 27924974 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting TGF-β1-Smad 2 signaling | ||
Reference Record 3
| PubMed ID | 27746237 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human,mice | Fibrosis Disease | Idiopathic pulmonary fibrosis |
| Process I | |||
| Process II | fibroblasts proliferation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting LXR pathway | ||
Reference Record 4
| PubMed ID | 27284727 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Cystic fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | Targeting CTGF | ||
Reference Record 5
| PubMed ID | 26828700 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human,mice | Fibrosis Disease | Dermal fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting casein kinase 1α (CK1α) and SHIP-1 | ||
Reference Record 6
| PubMed ID | 25097177 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human | Fibrosis Disease | Bone marrow fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 7
| PubMed ID | 24657879 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 8
| PubMed ID | 19701459 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Pulmonary fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | Targeting KGF/FGF7 | ||